Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT04979949), in which the TURKOVAC or CoronaVac vaccines w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ates, Ihsan, Batirel, Ayse, Aydin, Mehtap, Karadag, Fatma Yilmaz, Erden, Abdulsamet, Kucuksahin, Orhan, Armagan, Berkan, Guven, Serdar Can, Karakas, Ozlem, Gokdemir, Selim, Altunal, Lutfiye Nilsun, Buber, Aslihan Ayse, Gemcioglu, Emin, Zengin, Oguzhan, Inan, Osman, Sahiner, Enes Seyda, Korukluoglu, Gulay, Sezer, Zafer, Ozdarendeli, Aykut, Omma, Ahmet, Kara, Ates
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416156/
https://www.ncbi.nlm.nih.gov/pubmed/37515050
http://dx.doi.org/10.3390/vaccines11071234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416156/
https://www.ncbi.nlm.nih.gov/pubmed/37515050
http://dx.doi.org/10.3390/vaccines11071234

Ejemplares similares